HopeStage
Back to all studies
CompletedNCT01557569

Atomoxetine or Placebo and Time to Methamphetamine Relapse

About this titleRead the official source — NCT01557569
Medication studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Little RockSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2012
Recruitment status
Completed
Enrollment listed in the registry
20
Sponsor
University of Arkansas
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01557569
Official title
Show the full official title

Clinical Efficacy of Atomoxetine for Methamphetamine Dependence

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Little Rock

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Arkansas, a university.

Did this study involve medication?

Yes. The study involved medication, including Atomoxetine and placebo.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies